Absorbable Hemostatic Agent Downclassification Endorsed By Panel
This article was originally published in The Gray Sheet
Executive Summary
Content review of FDA's planned special controls guidance was instrumental in the General & Plastic Surgery Devices Panel's July 24 recommendation that absorbable hemostatic agents be downclassified from Class III to Class II
You may also be interested in...
Experts Recommend Downclassifying Absorbable Collagen Hemostatic Devices Despite Data Doubts
A panel of experts recommended the US Food and Drug Administration downclassify certain absorbable collagen hemostatic devices despite concerns there isn't sufficient clinical data to support the safety and efficacy of the surgical products.
CDRH Chief Pushes Office To Speed Up Device Reclassifications
FDA's device chief is putting more pressure on his office to get final device reclassifications out the door, and plans to release several more of them soon
CDRH Chief Pushes Office To Speed Up Device Reclassifications
FDA's device chief is putting more pressure on his office to get final device reclassifications out the door, and plans to release several more of them soon